Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

MOXIFLOXACIN HYDROC

Awarded
SPE2D926F7385Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Cardinal Health, Inc. has been awarded a delivery order under the base contract SPE2DX-25-D-8022 by the Defense Logistics Agency for the procurement of three bottles of MOXIFLOXACIN HYDROC (NSN 6505015090677) at a unit price of $5.06, totaling $15.18. The award was issued on July 16, 2026, with delivery scheduled for the same date, FOB destination, meaning the contractor is responsible for all costs and risks until the goods arrive at the designated delivery point—Electric Boat Corporation in North Stonington, Connecticut. The item is identified by a federal supply classification and manufacturer CAGE code 0THL4, with no alternate specifications or technical standards explicitly cited. Packaging must be shipped via the fastest traceable means, and parcel post is strictly prohibited; all packages and documents must be marked with both the delivery order number SPE2D926F7385 and the base contract number SPE2DX25D8022. No barcoding, MIL-STD requirements, or preservation methods are specified. Inspection and acceptance occur at the destination by the government, with conformity to contract terms being the sole criterion. Payment will be processed electronically through the Defense Finance and Accounting Service in Columbus, Ohio, using voucher-based systems consistent with DLA’s WAWF and EDI protocols. The awardee has self-certified as a small business with no other socioeconomic certifications, triggering potential reporting obligations under FAR 19.5. The contracting officer is Lisa Quinn, who also serves as the administrative point of contact, with no separate COR or COTR designated. No formal FAR clauses or attachments are listed, and the contract contains zero tolerance for quantity variance. Medical substitution is permitted under specified ranking, and the award is structured as a single-line-item delivery order under an IDIQ framework, with no options, extensions, or additional line items.

General Info

Cardinal Health awarded $15.18M for Moxifloxacin Hydrochloride under DLA contract SPE2DX25D8022 on July 16, 2026.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

Contract Value

$15.18

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Awardee

CARDINAL HEALTH, INC.View Profile

Award Issued Date

Documents

(2)

SPE2D926F7385.pdf

PDF

SPE2D926F7385.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2D926F7385 posted on DIBBS. Awardee: CARDINAL HEALTH, INC. (CAGE 00E55) Total Contract Price: $15.18 Award Date: 07-16-2026 Delivery order under: SPE2DX25D8022 Line items: - MOXIFLOXACIN HYDROC (NSN/Part 6505015090677, PR 7017529937)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency